MBX BiosciencesvsUnitedHealth

MBX and UNH stock compared: price, dividend, valuation and results, from SEC filings.

MBX

MBX Biosciences, Inc.

$53.41

Value $2.5B

-0.02%
MBX's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

MBX Biosciences (MBX) has a market value of $2.5B and UnitedHealth (UNH) $300B. Over the last year, with dividends, MBX moved +102.6% and UNH +8.2%. Dividend yield: MBX none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MBX$2.5B

    UNH$300B

    UNH is 118 times MBX

  • Revenue, 12 months

    MBX–

    UNH$450B

  • Net income, 12 months

    MBX-$145M

    UNH$15.9B

  • Operating margin

    MBX–

    UNH5.3%

  • ROIC

    MBX-21.0%

    UNH11.3%

    32.3 points apart

  • P/E

    MBX–

    UNH18.9

  • Dividend yield

    MBX0.0%

    UNH2.7%

    2.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MBX+102.6%

UNH+8.2%

100150200250DecFebAprJunAugOct
Returns by period
PeriodMBXWith dividendsUNHWith dividends
1 year since November 18, 2025+102.6%Price +102.6%+8.2%Price +5.4%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MBXMBX BiosciencesUNHUnitedHealth

Valuation

MBXUNH
Valuation
Price$53.41$330.48
Market value$2.5B$300B
Enterprise value (EV)$2.1B$346B
P/E–18.9
P/E, 5-year median–25.0
P/B5.42.9
EV/EBIT–14.5
Free cash flow yield–7.6%

Results and growth

MBXUNH
Results and growth
Revenue, 12 months–$450B
Net income, 12 months-$145M$15.9B
Free cash flow, 12 months-$99M$22.8B
Earnings per share, 12 months-$3.02$17.52
Revenue growth, year on year–11.8%
Revenue growth a year, past–+11.7%over 5 years
EPS growth a year, past–-3.8%over 5 years

Margins and returns on capital

MBXUNH
Margins and returns on capital
Gross margin–88.3%
Operating margin–5.3%
Net margin–3.5%
ROIC-21.0%11.3%
ROE-34.9%15.5%

Balance sheet

MBXUNH
Balance sheet
Cash$482M$28.5B
Total debt$3.3M$74.3B
Net debt / EBITDA–1.6
Interest cover–6.2×

Dividends and buybacks

MBXUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield0.0%1.8%
Shareholder yield–4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MBX or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, MBX Biosciences or UnitedHealth?

By market value, UnitedHealth ($300B) is about 118.2 times MBX Biosciences ($2.5B), at today's prices.

How did MBX and UNH stock do over the last 1 years?

Since November 18, 2025, MBX's price moved +102.6% and UNH's +5.4%. With dividends: MBX +102.6% (+102.6% a year), UNH +8.2% (+8.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, MBX or UNH?

The dividend yield at today's price is none for MBX Biosciences and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

Which is the better investment, MBX Biosciences or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.